Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo- and Active Controlled Study to Evaluate the Safety and Efficacy of GRT6005 in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

NCT01709214 is registered in ClinicalTrials.gov with Tris Pharma, Inc. as lead sponsor.

NCT NCT01709214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01709214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo- and Active Controlled Study to Evaluate the Safety and Efficacy of GRT6005 in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Lead sponsor
Tris Pharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 4, 2012
Completion date
April 4, 2014
Enrollment
619 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe chronic pain due to osteoarthritis of the knee